Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Clinical trial NCT00311155 · COMPLETED

Trial details

NCT number: NCT00311155
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2006-03-01
Primary completion: 2008-04-01
Enrollment: 694

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.